Section 1 Short title
This Act may be cited as the “COVID–19 Vaccine Accountability Act”.
COVID–19 Vaccine Accountability Act
A BILL
To amend title III of the Public Health Service Act to eliminate immunity for manufacturers of COVID–19 vaccines, and for other purposes.
Sec. 2 Liability of COVID–19 vaccine manufacturers
Covered countermeasure— Section 319F–3(i)(1) of the Public Health Service Act (42 U.S.C. 247d–6d(i)(1)) is amended by adding at the end the following:
Covered person— Section 319F–3(i)(2) of the Public Health Service Act (42 U.S.C. 247d–6d(i)(2)) is amended by adding at the end the following:
Limitation of liability— Section 319F–3 of the Public Health Service Act (42 U.S.C. 247d–6d) is amended by adding at the end the following:
“(j) Limitation on liability—Pursuant to, and consistent with, the sovereign immunity reservation specified in subsection (f), the liability of the United States for a death or injury caused by the administration of a vaccine for COVID–19 occurring on or after January 1, 2020 shall not exceed $10,000.”